Literature DB >> 33067635

Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial.

Giovanna Liuzzo1, Carlo Patrono2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33067635     DOI： 10.1093/eurheartj/ehaa836

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  2 in total

1.  Effectiveness and Safety of DOACs vs. Warfarin in Patients With Atrial Fibrillation and Frailty: A Systematic Review and Meta-Analysis.

Authors:  Shan Zeng; Yuxiang Zheng; Jingzhou Jiang; Jianyong Ma; Wengen Zhu; Xingming Cai
Journal:  Front Cardiovasc Med       Date:  2022-06-24

2.  Laboratory Test Predictors for Major Bleeding in Elderly (≥80 Years) Patients With Nonvalvular Atrial Fibrillation Treated With Edoxaban 15 mg: Sub-Analysis of the ELDERCARE-AF Trial.

Authors:  Takeshi Mikami; Kagami Hirabayashi; Keisuke Okawa; Tetsuo Betsuyaku; Saori Watanabe; Yuki Imamura; Kimihiko Tanizawa; Takuya Hayashi; Masaharu Akao; Takeshi Yamashita; Ken Okumura
Journal:  J Am Heart Assoc       Date:  2022-09-03       Impact factor: 6.106
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.